Publisher(favicon_url='https://s3.massive.com/public/assets/news/favicons/globenewswire.ico', homepage_url='https://www.globenewswire.com', logo_url='https://s3.massive.com/public/assets/news/logos/globenewswire.svg', name='GlobeNewswire Inc.')•2024-09-03
IBN Announces Latest Episode of The BioMedWire Podcast featuring John Climaco, CEO of CNS Pharmaceuticals Inc.CNSP — CNS Pharmaceuticals Inc
NASDAQ · Pharmaceuticals · Pharmaceuticals
$2.46-68.42%Market cap1.40M
- Latest Close
- $2.46
- 30-Day Move
- -68.4%
- Market Cap
- $1M
- Shares Outstanding
- 620,000
- P/B Ratio
- 1.12
- ROE
- -240.6%
Analyst consensus: Buy · 8 analysts
NASDAQ:CNSPPharmaceuticals / PharmaceuticalsDelayed public snapshot
CNS Pharmaceuticals Inc
A read-only Alphactor snapshot forCNS Pharmaceuticals Inc. It uses the same research structure as the app, but with delayed data and shallow depth so search visitors can evaluate the stock before signing up.
Snapshot as of2026-04-21
Topline snapshot
Latest Close
$2.46
30-Day Move
-68.4%
Market Cap
$1M
Shares Outstanding
620,000
P/B Ratio
1.12
ROE
-240.6%
Not investment advice. Signals and scores shown here are model outputs derived from historical data, not recommendations. Past performance does not guarantee future results. Do your own research before trading. Full disclaimer
Chart snapshot
$2.46
-68.4%last 90 delayed daily bars
Market cap$1M
90D High
$8.92
90D Low
$2.06
Avg Volume
40,353
What stands out
CNSP is down 68.4% over the last 30 trading days shown on this page.
Latest operating income is $-16M, which helps anchor the headline ratios with an actual earnings figure.
Research snapshot
Dark Pool Short %
70.2%
Fundamentals snapshot
Latest Close
$2.46
30-Day Move
-68.4%
Market Cap
$1M
Shares Outstanding
620,000
P/B Ratio
1.12
ROE
-240.6%
ROA
-170.8%
Debt / Equity
0.05
Current Ratio
3.43
Latest Revenue
$0
Financial statement snapshot
Revenue
$0
Gross Profit
--
Operating Income
$-16M
Net Income
$-16M
Gross Margin
--
Net Margin
--
Current Ratio
3.43
Debt / Equity
0.05
Quality snapshot
Altman Z
-21.64
Distress
Piotroski
1
Weak (0-3)
Cash Conversion
0.87x
Rule of 40
--
Insufficient data
Annual financial history
Annual performance mix
| Period | Revenue | Operating Income | Net Income | Free Cash Flow |
|---|---|---|---|---|
| 2022-12-31 | $0 | $-15M | $-15M | $-11M |
| 2023-12-31 | $0 | $-19M | $-19M | $-14M |
| 2024-12-31 | $0 | $-15M | $-15M | $-17M |
| 2025-12-31 | $0 | $-16M | $-16M | $-14M |
After signup
The app opens the full statement deep dive
Extend the history well beyond this public snapshot to inspect longer cycles and regime changes.
Move from summary lines into detailed balance-sheet and cash-flow rows for working capital, debt, and capex analysis.
Cross-link statement changes with alerts, watchlists, and saved research workflows after signup.
News snapshot
Publisher(favicon_url='https://s3.massive.com/public/assets/news/favicons/benzinga.ico', homepage_url='https://www.benzinga.com/', logo_url='https://s3.massive.com/public/assets/news/logos/benzinga.svg', name='Benzinga')•2024-02-09
Top 5 Health Care Stocks That Are Preparing To Pump In FebruaryPublisher(favicon_url='https://s3.massive.com/public/assets/news/favicons/benzinga.ico', homepage_url='https://www.benzinga.com/', logo_url='https://s3.massive.com/public/assets/news/logos/benzinga.svg', name='Benzinga')•2024-01-30
Why UPS Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionPublisher(favicon_url='https://s3.massive.com/public/assets/news/favicons/benzinga.ico', homepage_url='https://www.benzinga.com/', logo_url='https://s3.massive.com/public/assets/news/logos/benzinga.svg', name='Benzinga')•2024-01-30
Why Super Micro Computer Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving PremarketPublisher(favicon_url='https://s3.massive.com/public/assets/news/favicons/benzinga.ico', homepage_url='https://www.benzinga.com/', logo_url='https://s3.massive.com/public/assets/news/logos/benzinga.svg', name='Benzinga')•2023-10-16
Why Streamline Health Solutions Shares Are Trading Lower By Over 68%? Here Are Other Stocks Moving In Monday's Mid-Day SessionAfter signup
The full sentiment workspace adds context
Go past the public headlines into fuller article history, source cross-checks, and deeper narrative tracking.
Tie news into alerts, watchlists, and conviction changes instead of browsing one static batch of stories.
Recent insider transactions
| Date | Name | Type | Shares | Price |
|---|---|---|---|---|
| 2026-03-02 | Faulkner Eric | A | 9,500 | $0.00 |
| 2026-03-02 | O'Loughlin Steve | A | 9,500 | $0.00 |
| 2026-01-01 | Levin Rami | A | 19,000 | $0.00 |
| 2025-11-17 | Cockroft Bettina M. | A | 1,517 | $0.00 |
| 2025-11-17 | Mahery Amy | A | 1,517 | $0.00 |
| 2025-11-17 | Charles Faith L. | A | 1,517 | $0.00 |
| 2025-11-17 | Gumulka Jerzy | A | 1,517 | $0.00 |
| 2025-11-17 | Downs Christopher | A | 4,881 | $0.00 |
Institutional holders snapshot
Geode Capital Management
Filed 2025-11-12
--
--
Dark-pool activity snapshot
Analyst consensus?
Rating(?)
4.13
Consensus
BuyTarget Mean(?)
—
Target High(?)
—
Target Low(?)
—
Analysts
8
For informational and educational purposes only. Not financial advice. Learn more
Related reading
Research and strategy guides from the alphactor blog.
Accruals Quality: How to Spot Earnings That Aren't Real
Accruals measure the gap between reported earnings and actual cash. Widening accruals is one of the most reliable red flags in financial analysis — Sloan's…
Altman Z-Score: A Bankruptcy Predictor That Still Works
Edward Altman's 1968 discriminant model predicts bankruptcy within two years about 72% of the time at its distress threshold.
Balance Sheet Deep Dive
Balance sheet changes lead income statements by 2-6 quarters. Net debt, receivables days, and goodwill are the lines that move stocks first.